prednicortone vet 5 mg tableta
dechra regulatory b.v. - prednisolon - tableta - glukokortikoidy - psi, kočky
hedylon 25 mg 25 mg tableta
livisto int'l, s.l. - prednisolon - tableta - glukokortikoidy - psi
hedylon 5 mg 5 mg tableta
livisto int'l, s.l. - prednisolon - tableta - glukokortikoidy - psi, kočky
depedin veyx injekční suspenze
veyx-pharma gmbh - prednisolon, kombinace - injekční suspenze - glukokortikoidy - koně, kočky, psi
mitex ušní kapky, suspenze
vetviva richter gmbh - prednisolon a antiinfectives - ušní kapky, suspenze - kortikosteroidy a antiinfectives v kombinaci - kočky, psi
alphaderm plus kožní sprej, roztok
alpha-vet Állatgyógyászati kft. - prednisolon a antibiotika - kožní sprej, roztok - kortikosteroidy, slabý, kombinace s antibiotiky - psi
cortizeme kožní suspenze
virbac sa - prednisolon a antibiotika - kožní suspenze - kortikosteroidy, slabý, kombinace s antibiotiky - kočky, psi
abiraterone accord
accord healthcare s.l.u. - abirateron acetátu - prostatetické novotvary - endokrinní terapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateron acetátu - prostatetické novotvary - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateron acetátu - prostatetické novotvary - endokrinní terapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.